Estrogen-regulated AGR3 activates the estrogen receptor signaling pathway to promote tamoxifen resistance in breast cancer

被引:0
|
作者
Rui Jiang
Yongjie Sun
Xiao Chen
Peng Shi
机构
[1] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Department of Oncology
[2] Shandong Provincial ENT Hospital,Department of Breast and Thyroid Diseases, Shandong Second Provincial General Hospital
[3] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Department of Breast and Thyroid Surgery
来源
Breast Cancer Research and Treatment | 2021年 / 190卷
关键词
Estrogen; AGR3; ER signaling pathway; Breast cancer; Tamoxifen resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:203 / 211
页数:8
相关论文
共 50 条
  • [41] Different affinities of tamoxifen binding sites in the estrogen receptor of breast cancer
    Calzada, L
    Toboada, J
    Martínez, JM
    Téllez, J
    MEDICAL SCIENCE RESEARCH, 1998, 26 (12): : 829 - 830
  • [42] Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling
    Thrane, Susan
    Lykkesfeldt, Anne E.
    Larsen, Mathilde S.
    Sorensen, Boe S.
    Yde, Christina W.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (01) : 71 - 80
  • [43] Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling
    Susan Thrane
    Anne E. Lykkesfeldt
    Mathilde S. Larsen
    Boe S. Sorensen
    Christina W. Yde
    Breast Cancer Research and Treatment, 2013, 139 : 71 - 80
  • [44] Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
    Pin Gao
    Xiang Wang
    Ying Jin
    Wenquan Hu
    Yajun Duan
    Aiping Shi
    Ye Du
    Dong Song
    Ming Yang
    Sijie Li
    Bing Han
    Gang Zhao
    Hongquan Zhang
    Zhimin Fan
    Qing Robert Miao
    Breast Cancer Research, 20
  • [45] let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast Cancer
    Yingchun Zhao
    Caishu Deng
    Weida Lu
    Jing Xiao
    Danjun Ma
    Mingxi Guo
    Robert R. Recker
    Zoran Gatalica
    Zhaoyi Wang
    Gary Guishan Xiao
    Molecular Medicine, 2011, 17 : 1233 - 1241
  • [46] Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
    Gao, Pin
    Wang, Xiang
    Jin, Ying
    Hu, Wenquan
    Duan, Yajun
    Shi, Aiping
    Du, Ye
    Song, Dong
    Yang, Ming
    Li, Sijie
    Han, Bing
    Zhao, Gang
    Zhang, Hongquan
    Fan, Zhimin
    Miao, Qing Robert
    BREAST CANCER RESEARCH, 2018, 20
  • [47] Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
    Zhao, Yiru Chen
    Erdogan, Zeynep Madak
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (109):
  • [48] Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer
    Ijichi, Nobuhiro
    Shigekawa, Takashi
    Ikeda, Kazuhiro
    Horie-Inoue, Kuniko
    Fujimura, Tetsuya
    Tsuda, Hitoshi
    Osaki, Akihiko
    Saeki, Toshiaki
    Inoue, Satoshi
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 123 (1-2): : 1 - 7
  • [49] Systemic identification of estrogen-regulated genes in breast cancer cells through cap analysis of gene expression mapping
    Yamaga, Ryonosuke
    Ikeda, Kazuhiro
    Boele, Joost
    Horie-Inoue, Kuniko
    Takayama, Ken-ichi
    Urano, Tomohiko
    Kaida, Kaoru
    Carninci, Piero
    Kawai, Jun
    Hayashizaki, Yoshihide
    Ouchi, Yasuyoshi
    de Hoon, Michiel
    Inoue, Satoshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 447 (03) : 531 - 536
  • [50] SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells
    Jin, Ming Li
    Yang, Liu
    Jeong, Kwang Won
    THERANOSTICS, 2022, 12 (12): : 5761 - 5775